Stockscreener 앱 받기
6.40
0.31%
0.02
전일 마감가:
$6.38
열려 있는:
$6.35
하루 거래량:
55,979
Relative Volume:
0.20
시가총액:
$233.00M
수익:
-
순이익/손실:
$-41.36M
주가수익비율:
-3.9024
EPS:
-1.64
순현금흐름:
$-42.09M
1주 성능:
-9.22%
1개월 성능:
+11.89%
6개월 성능:
+171.19%
1년 성능:
+213.73%
1일 변동 폭
$6.16
$6.56
1주일 범위
$5.66
$7.5064
52주 변동 폭
$0.8981
$16.34
Armata Pharmaceuticals Inc Stock (ARMP) Company Profile
명칭
Armata Pharmaceuticals Inc
전화
310-655-2928
주소
4503 Glencoe Avenue, Marina del Rey, CA
ARMP을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ARMP
Armata Pharmaceuticals Inc
|
6.40 | 232.28M | 0 | -41.36M | -42.09M | -1.64 |
|
VRTX
Vertex Pharmaceuticals Inc
|
441.36 | 111.36B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
733.04 | 77.98B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
800.01 | 50.33B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
359.27 | 47.46B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
338.19 | 37.43B | 4.98B | 69.59M | 525.67M | 0.5197 |
Armata Pharmaceuticals Inc Stock (ARMP) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2019-06-19 | 개시 | Ladenburg Thalmann | Buy |
Armata Pharmaceuticals Inc 주식(ARMP)의 최신 뉴스
Armata Pharmaceuticals (ARMP) Price Target Increased by 33.33% to 12.24 - Nasdaq
Block Trades: Is Armata Pharmaceuticals Inc stock a smart retirement pickTrade Risk Assessment & Growth Focused Stock Pick Reports - baoquankhu1.vn
Armata Wins FDA Support to Advance Bacteriophage to Phase 3 - TipRanks
Armata Pharmaceuticals Advances AP-SA02 to Phase 3 Study - TradingView — Track All Markets
Armata Pharmaceuticals Announces End-of-Phase 2 Meeting with FDA and Plans to Advance AP-SA02 to a Phase 3 Superiority Study in Complicated BacteremiaStaphylococcusaureus - PR Newswire
ARMP Stock Quote - richtv.io
Why Armata Pharmaceuticals Inc. (TG1N) stock is upgraded to buyJuly 2025 Weekly Recap & Target Return Focused Picks - Улправда
What valuation multiples suggest for Armata Pharmaceuticals Inc. stock2025 Technical Overview & Consistent Income Trade Recommendations - ulpravda.ru
Armata Pharmaceuticals, Inc. Common Stock (NY: ARMP - FinancialContent
Will Armata Pharmaceuticals Inc. stock benefit from upcoming earnings reportsMarket Trend Report & Entry and Exit Point Strategies - Улправда
Will Armata Pharmaceuticals Inc. stock continue dividend increases2025 Price Targets & Community Consensus Trade Alerts - Улправда
Will Armata Pharmaceuticals Inc. stock gain from lower inflationJuly 2025 Review & Fast Moving Stock Trade Plans - Улправда
Trade Recap: Will Armata Pharmaceuticals Inc. stock deliver long term returnsJuly 2025 Catalysts & Accurate Entry/Exit Alerts - Улправда
Can Armata Pharmaceuticals Inc. stock attract ESG capital inflowsMarket Risk Summary & Scalable Portfolio Growth Methods - ulpravda.ru
Will Armata Pharmaceuticals Inc. stock maintain dividend yield2025 Geopolitical Influence & Advanced Technical Signal Analysis - Улправда
Will Armata Pharmaceuticals Inc. stock pay special dividendsMarket Sentiment Review & Real-Time Stock Movement Alerts - Улправда
About Us | Oil & Gas JournalArmata Pharmaceuticals, Inc. Common Stock (NYSE:ARMP) Detailed Stock Data - FinancialContent
Will Armata Pharmaceuticals Inc. stock outperform energy sector in 20252026 world cup usa national team round of 16 goalkeepers counter attacking tactical prediction expert opinion - ulpravda.ru
Jones Trading initiates coverage of Armata Pharmaceuticals (ARMP) with buy recommendation - MSN
Armata Pharmaceuticals (NYSEAMERICAN:ARMP) Coverage Initiated by Analysts at Jones Trading - Defense World
Is Armata Pharmaceuticals (ARMP) Stock Outpacing Its Medical Peers This Year? - MSN
Jones Trading Initiates Coverage on Armata Pharmaceuticals (ARMP - GuruFocus
Jones Trading Initiates Coverage on Armata Pharmaceuticals (NYSEAMERICAN:ARMP) - MarketBeat
Jones Trading initiates coverage on Armata Pharmaceuticals stock with Buy rating - Investing.com Canada
Published on: 2026-01-05 08:37:29 - moha.gov.vn
Gap Down: Will Armata Pharmaceuticals Inc stock maintain dividend yieldMarket Growth Report & Risk Controlled Stock Pick Alerts - moha.gov.vn
ARMATA PHARMACEUTICALS INC(NYSEARCA:ARMP) stock News - Chartmill
Day Trade: Is Armata Pharmaceuticals Inc stock among top earnings playsLayoff News & Fast Exit and Entry Strategy Plans - moha.gov.vn
Will Armata Pharmaceuticals Inc stock maintain dividend yieldMarket Risk Summary & Growth Focused Entry Reports - moha.gov.vn
Pharma News: Will Armata Pharmaceuticals Inc stock gain from lower inflation2025 Market WrapUp & Real-Time Buy Signal Alerts - moha.gov.vn
Armata Pharmaceuticals (NYSEAMERICAN:ARMP) Trading 2.7% HigherStill a Buy? - MarketBeat
Armata Pharmaceuticals (NYSEAMERICAN:ARMP) Trading 2.7% Higher – Still a Buy? - Defense World
Aug Closing: Will Armata Pharmaceuticals Inc TG1N stock benefit from sector leadershipJuly 2025 Fed Impact & Consistent Growth Equity Picks - moha.gov.vn
Is Armata Pharmaceuticals Inc. stock trading near support levelsJuly 2025 Price Swings & Fast Moving Market Watchlists - DonanımHaber
Can Armata Pharmaceuticals Inc. stock deliver surprise earnings beatDip Buying & Safe Capital Growth Tips - Улправда
Can Armata Pharmaceuticals Inc. (TG1N) stock sustain double digit ROEJuly 2025 Catalysts & Accurate Entry/Exit Alerts - Улправда
Why Armata Pharmaceuticals Inc. stock attracts global investorsWeekly Profit Recap & Long-Term Growth Portfolio Plans - Улправда
Armata Pharmaceuticals Earnings Notes - Trefis
Why Armata Pharmaceuticals Inc. stock attracts wealthy investors2025 Buyback Activity & Free Real-Time Market Sentiment Alerts - Улправда
How Armata Pharmaceuticals Inc. stock reacts to bond yields2025 Volume Leaders & High Yield Equity Trading Tips - bolumsonucanavari.com
Is Armata Pharmaceuticals Inc. stock dividend growth reliableShare Buyback & Stepwise Trade Signal Implementation - DonanımHaber
Merger Talk: Can Armata Pharmaceuticals Inc. stock attract ESG capital inflowsWeekly Trade Review & Long-Term Growth Stock Strategies - DonanımHaber
Published on: 2025-12-19 11:47:18 - DonanımHaber
Can Armata Pharmaceuticals Inc. stock sustain revenue growth2025 Top Gainers & Safe Entry Trade Signal Reports - Улправда
New Strong Sell Stocks for May 8th - sharewise.com
Free cash flow per share of Armata Pharmaceuticals, Inc. – LS:A2PKLC - TradingView
Why Armata Pharmaceuticals Inc. (TG1N) stock benefits from AI revolution2025 Big Picture & AI Forecasted Stock Moves - Newser
Is Armata Pharmaceuticals Inc. (TG1N) stock testing key supportJuly 2025 Pullbacks & Verified Momentum Stock Watchlist - Newser
Why Armata Pharmaceuticals Inc. (TG1N) stock attracts HNW investorsPortfolio Growth Summary & Weekly Top Gainers Trade List - Newser
Armata Pharmaceuticals (ARMP) Surges 103.2%: Is This an Indication of Further Gains? - MSN
Will Armata Pharmaceuticals Inc. stock announce special dividendBull Run & Real-Time Chart Breakout Alerts - Newser
Armata Pharmaceuticals Inc (ARMP) 재무 분석
매출
순이익
현금흐름
주당 순 이익
4.73%
0.92%
자본화:
|
볼륨(24시간):